Psychedelic drugs: the ups and downs of ecstasy (Q44894621)

7 December 2017

Psychedelic drugs: the ups and downs of ecstasy (English)

1 reference

7 December 2017

1

Erika Check

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

7 December 2017

1 reference

7 December 2017

429

1 reference

7 December 2017

6988

1 reference

7 December 2017

126-128

1 reference

https://scigraph.springernature.com/pub.10.1038/429126a

7 December 2017

0 references

cites work

The psychopharmacology of hallucinogens

1 reference

Subjective reports of the effects of MDMA in a clinical setting.

21 January 2018

1 reference

Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration.

21 January 2018

1 reference

(+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates

21 January 2018

1 reference

The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

21 January 2018

1 reference

Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (MDMA; "Ecstasy"): a controlled study in humans.

21 January 2018

1 reference

Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings.

21 January 2018

1 reference

Ecstasy (MDMA): a review of its possible persistent psychological effects

21 January 2018

1 reference

Psychological and cardiovascular effects and short-term sequelae of MDMA ("ecstasy") in MDMA-naïve healthy volunteers.

21 January 2018

1 reference

Caveat emptor: editors beware

21 January 2018

1 reference

Retracted article on dopaminergic neurotoxicity of MDMA

21 January 2018

1 reference

21 January 2018

1 reference

Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals.

21 January 2018

1 reference

7 January 2021

5-Hydroxyindoleacetic acid in cerebrospinal fluid reflects serotonergic damage induced by 3,4-methylenedioxymethamphetamine in CNS of non-human primates

1 reference

7 January 2021

Long-term neuropsychiatric consequences of "ecstasy" (MDMA): a review

1 reference

7 January 2021

Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA (“Ecstasy”) in MDMA-Naïve Healthy Volunteers

1 reference

7 January 2021

Psychobiologic effects of 3,4-methylenedioxymethamphetamine in humans: methodological considerations and preliminary observations

1 reference

7 January 2021

Identifiers

DOI

10.1038/429126A

1 reference

Dimensions Publication ID

7 December 2017

1048772182

0 references

Fatcat ID

release_25yov24ycvdxhbc3snnku2hb3y

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/25yov24ycvdxhbc3snnku2hb3y

24 November 2022

mapped directly with Wikidata item

1 reference